Yujie Feng - Search Results

Year	Number of Results
2004	1
2005	2
2007	2
2008	4
2009	8
2010	17
2011	16
2012	15
2013	7
2014	10
2015	21
2016	21
2017	23
2018	31
2019	33
2020	46
2021	51
2022	45
2023	39
2024	43
2025	52
2026	44

1

A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor Activities.

Cui X, Jia H, Xin H, Zhang L, Chen S, Xia S, Li X, Xu W, Chen X, Feng Y, Wei X, Yu H, Wang Y, Zhan Y, Zhu X, Zhang X. Cui X, et al. Among authors: feng y. Front Immunol. 2021 Dec 2;12:778978. doi: 10.3389/fimmu.2021.778978. eCollection 2021. Front Immunol. 2021. PMID: 34925354 Free PMC article.

2

Tumor-derived exosomal LINC01812 induces M2 macrophage polarization to promote perineural invasion in cholangiocarcinoma.

Wang Q, Sun Z, Guo J, Li H, Zhang J, Zhang B, Zhou B, Feng Y. Wang Q, et al. Among authors: feng y. Cancer Lett. 2025 May 1;617:217596. doi: 10.1016/j.canlet.2025.217596. Epub 2025 Mar 11. Cancer Lett. 2025. PMID: 40081462 Free article.

3

An antibody cocktail targeting two different CD73 epitopes enhances enzyme inhibition and tumor control.

Xu JG, Chen S, He Y, Zhu X, Wang Y, Ye Z, Zhou JC, Wu X, Zhang L, Ren X, Jia H, Yu H, Wei X, Feng Y, Chen X, Cui X, Pan X, Wang S, Xia S, Shang H, Pu Y, Xu W, Li H, Chen Q, Chen Z, Wang M, Yan X, Shi H, Li M, Xia Y, Bellelli R, Dong S, He J, Huang J, Cai CL, Zhu X, Zhan Y, Wan L. Xu JG, et al. Among authors: feng y. Nat Commun. 2024 Dec 30;15(1):10872. doi: 10.1038/s41467-024-55207-9. Nat Commun. 2024. PMID: 39738003 Free PMC article.

4

Sodium-glucose cotransporter 2 inhibitors alleviate renal fibrosis in diabetic kidney disease by inhibiting Hmgcs2 and Btg2 in proximal tubular cells.

Yan S, Luo M, Zhou R, Peng F, Zhang M, Feng Y, Zhao L, Yang L, Cheng Y. Yan S, et al. Among authors: feng y. J Transl Med. 2025 Aug 25;23(1):959. doi: 10.1186/s12967-025-06788-6. J Transl Med. 2025. PMID: 40855324 Free PMC article.

5

Profiles of parental bonding and childhood trauma in a clinical sample: Implications for coping strategies in adulthood among Chinese young adults.

Jin L, Chen J, Huang QL, Hu H, Wang P, Yujie FENG, Han Y, He X, Liang F, Zhao L, Wang Y, Han J, Wu H, Yan Q, Ji Y, Yi Q, Lv Q, Yi Z. Jin L, et al. Among authors: yujie feng. J Affect Disord. 2026 Jan 15;393(Pt A):120310. doi: 10.1016/j.jad.2025.120310. Epub 2025 Sep 9. J Affect Disord. 2026. PMID: 40935262

6

Dual blockade of IL-17A and IL-36 pathways via a bispecific antibody exhibits enhanced anti-inflammatory potency.

Ma X, Zhang S, Ren X, Feng Y, Li H, Chen S, Xu J, Wang Y, Peng GY, Yan Q, Jia H, Xia S, Cui X, Chen X, Pan X, Wang S, Yu H, Wei X, Li M, Liu B, Xu J, Qian Q, Zhu X, Zhan Y, Lu L. Ma X, et al. Among authors: feng y. Front Immunol. 2024 Nov 12;15:1434127. doi: 10.3389/fimmu.2024.1434127. eCollection 2024. Front Immunol. 2024. PMID: 39600699 Free PMC article.

7

LINC01978 drives perineural invasion in cholangiocarcinoma through tumor-neural crosstalk and CCL2-mediated macrophage recruitment.

Li H, Zhou R, Wang X, Sun Z, Ma K, Zhang B, Wang Q, Feng C, Zhou B, Feng Y. Li H, et al. Among authors: feng y. Cancer Lett. 2026 Apr 10;643:218304. doi: 10.1016/j.canlet.2026.218304. Epub 2026 Feb 6. Cancer Lett. 2026. PMID: 41655942 Free article.

8

Mechanosensory channels mediate ER Ca²⁺ transients to trigger assembly of autophagosome initiation sites for degradation of ER subdomains.

Ma X, Cheng Z, Zhao H, Zhang H, Xiao K, Xie J, Feng Y, Yang C, Feng Y, Wang X, Xiang Y, Hu J, Zheng Q, Ji W, Zhang H. Ma X, et al. Among authors: feng y. Mol Cell. 2026 Apr 2;86(7):1377-1396.e6. doi: 10.1016/j.molcel.2026.03.002. Mol Cell. 2026. PMID: 41932312

9

FEN1 promotes cancer progression of cholangiocarcinoma by regulating the Wnt/β-catenin signaling pathway.

Yuwei X, Bingzi D, Zhaowei S, Yujie F, Wei Z, Kun L, Kui L, Jingyu C, Chengzhan Z. Yuwei X, et al. Among authors: yujie f. Dig Liver Dis. 2024 Apr;56(4):695-704. doi: 10.1016/j.dld.2023.08.050. Epub 2023 Aug 28. Dig Liver Dis. 2024. PMID: 37648642

10

Recibokibart, an anti-IL-36 receptor monoclonal antibody, for treating generalized pustular psoriasis: Phase 1b trial.

Qian Q, Yang B, Lu X, Zhang Z, Chen J, Kuang Y, Zhang C, Man X, Su J, Ma C, Zhou G, Li B, Situ X, Ma X, Yang Y, Feng Y, Chen S, Zhan Y, Chen Q, Zhu X, Wang J, Zhang F. Qian Q, et al. Among authors: feng y. J Eur Acad Dermatol Venereol. 2025 Jun;39(6):e544-e546. doi: 10.1111/jdv.20511. Epub 2025 Jan 4. J Eur Acad Dermatol Venereol. 2025. PMID: 39754490 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

444 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

444 results

Results by year